<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="Activity\PMC7667629\results\search\disease\results.xml">
  <result pre="the lower age limit for treatment of bronchopulmonary infections in" exact="cystic fibrosis" post="and complicated urinary tract infections. For colistin/colistimethate sodium the"/>
  <result pre="(ciprofloxacin, amoxicillin/clavulanic acid, cefuroxime sodium and teicoplanin), followed by community-acquired" exact="pneumonia" post="(ceftazidime, cefuroxime axetil and fosfomycin), gonorrhoea (cefuroxime axetil, cefuroxime"/>
  <result pre="(imipenem/cilastatin and cefuroxime sodium) ranked at an equal rate with" exact="urethritis" post="(cefuroxime axetil and amoxicillin), gynaecological infections (piperacillin/tazobactam and cefuroxime"/>
  <result pre="For instance the following indications were removed (antibiotics between brackets):" exact="sinusitis" post="(ceftriaxone), tonsillitis (amoxicillin/clavulanic acid), asymptomatic bacteriuria and acute cystitis"/>
  <result pre="the following indications were removed (antibiotics between brackets): sinusitis (ceftriaxone)," exact="tonsillitis" post="(amoxicillin/clavulanic acid), asymptomatic bacteriuria and acute cystitis during pregnancy"/>
  <result pre="brackets): sinusitis (ceftriaxone), tonsillitis (amoxicillin/clavulanic acid), asymptomatic bacteriuria and acute" exact="cystitis" post="during pregnancy (fosfomycin trometamol oral solution), hospital-acquired pneumonia (levofloxacin),"/>
  <result pre="and acute cystitis during pregnancy (fosfomycin trometamol oral solution), hospital-acquired" exact="pneumonia" post="(levofloxacin), bronchitis (amoxicillin) or Clostridioides difficile infection (vancomycin oral"/>
  <result pre="Unchanged 2 4.4. Warnings 15 Amendment/harmonisation 15 a Patients with" exact="glucose-6-phosphate dehydrogenase deficiency." post="All referrals resulted in a change in section 4.2."/>
  <result pre="The majority of the harmonised contraindications were regarding information on" exact="hypersensitivity" post="(meropenem, amoxicillin/clavulanic acid, piperacillin/tazobactam, ceftazidime, imipenem/cilastatin, cefuroxime axetil, teicoplanin,"/>
  <result pre="of evidence) and for colistin/colistimethate sodium-containing products in patients with" exact="myasthenia gravis" post="(replacement with a warning in section 4.4). The section"/>
  <result pre="were included. For colistin or colistimethate sodium, in addition to" exact="myasthenia gravis" post="mentioned above, a warnings advising against concurrent administration of"/>
  <result pre="instance, ceftriaxone should not be used for the treatment of" exact="pharyngitis" post="and amoxicillin/clavulanic acid should not be used for tonisillitis"/>
  <result pre="of EU regulatory label changes for diclofenac in people with" exact="cardiovascular disease" post="in four countries: Interrupted time series regression analysis.Br J"/>
 </snippets>
</snippetsTree>
